THIENOPYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION, COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE PREPARATION OF MEDICAMENTS

The invention relates to a compound of formula (1): in which R1 and R2 each independently represent a C1-6alkyl, C3-6alkenyl, C3-6cycloalkylC1-3alkyl or C3-6cycloalkyl; each of which is optionally substituted by 1 to 3 halogen atoms; R3 is isoxazolidin-2-ylcarbonyl or tetrahydroisoxazin-2-ylcarbonyl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RUKHSANA TASNEEM RASUL, MARTIN EDWARD COOPER, RACHEL HEULWEN REYNOLDS, ANTHONY HOWARD INGALL, SIMON DAVID GUILE
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RUKHSANA TASNEEM RASUL
MARTIN EDWARD COOPER
RACHEL HEULWEN REYNOLDS
ANTHONY HOWARD INGALL
SIMON DAVID GUILE
description The invention relates to a compound of formula (1): in which R1 and R2 each independently represent a C1-6alkyl, C3-6alkenyl, C3-6cycloalkylC1-3alkyl or C3-6cycloalkyl; each of which is optionally substituted by 1 to 3 halogen atoms; R3 is isoxazolidin-2-ylcarbonyl or tetrahydroisoxazin-2-ylcarbonyl wherein each ring is optionally substituted by one hydroxy group; Q is -CO- or -C(R4)(R5)- in which R4 is a hydrogen atom or C1-4alkyl and R5 is a hydrogen atom or hydroxy group; and Ar is a 5- to 10-membered aromatic ring system in which up to 4 ring atoms may be heteroatoms independently selected from the group consisting of nitrogen, oxygen and sulphur, the ring system being optionally substituted by one or more substituents as defined in the specification. It also relates to methods of preparing, pharmaceutical compositions containing and methods of using the compound of the formula (1), particularly in the modulation of autoimmune disease.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IL159785A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IL159785A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IL159785A3</originalsourceid><addsrcrecordid>eNqFjTEKwkAQRdNYiHoFmQPEQkTUctlMzIA7s-yshVUIslaigXgDL24iKeysPu_zPn-avWNFyOIvgRwVxFiQMGoOPohFVSglQKyQQt-gN8HEXsjBivOiNIB-IZASHwfVgeFi3JwVgXiA3zlICa5_ssYhR51nk1tz79JizFm2LDHaapXaZ526trmmR3rVdFpvD7v91mz-Ch8lnTxc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THIENOPYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION, COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE PREPARATION OF MEDICAMENTS</title><source>esp@cenet</source><creator>RUKHSANA TASNEEM RASUL ; MARTIN EDWARD COOPER ; RACHEL HEULWEN REYNOLDS ; ANTHONY HOWARD INGALL ; SIMON DAVID GUILE</creator><creatorcontrib>RUKHSANA TASNEEM RASUL ; MARTIN EDWARD COOPER ; RACHEL HEULWEN REYNOLDS ; ANTHONY HOWARD INGALL ; SIMON DAVID GUILE</creatorcontrib><description>The invention relates to a compound of formula (1): in which R1 and R2 each independently represent a C1-6alkyl, C3-6alkenyl, C3-6cycloalkylC1-3alkyl or C3-6cycloalkyl; each of which is optionally substituted by 1 to 3 halogen atoms; R3 is isoxazolidin-2-ylcarbonyl or tetrahydroisoxazin-2-ylcarbonyl wherein each ring is optionally substituted by one hydroxy group; Q is -CO- or -C(R4)(R5)- in which R4 is a hydrogen atom or C1-4alkyl and R5 is a hydrogen atom or hydroxy group; and Ar is a 5- to 10-membered aromatic ring system in which up to 4 ring atoms may be heteroatoms independently selected from the group consisting of nitrogen, oxygen and sulphur, the ring system being optionally substituted by one or more substituents as defined in the specification. It also relates to methods of preparing, pharmaceutical compositions containing and methods of using the compound of the formula (1), particularly in the modulation of autoimmune disease.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20091118&amp;DB=EPODOC&amp;CC=IL&amp;NR=159785A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20091118&amp;DB=EPODOC&amp;CC=IL&amp;NR=159785A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RUKHSANA TASNEEM RASUL</creatorcontrib><creatorcontrib>MARTIN EDWARD COOPER</creatorcontrib><creatorcontrib>RACHEL HEULWEN REYNOLDS</creatorcontrib><creatorcontrib>ANTHONY HOWARD INGALL</creatorcontrib><creatorcontrib>SIMON DAVID GUILE</creatorcontrib><title>THIENOPYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION, COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE PREPARATION OF MEDICAMENTS</title><description>The invention relates to a compound of formula (1): in which R1 and R2 each independently represent a C1-6alkyl, C3-6alkenyl, C3-6cycloalkylC1-3alkyl or C3-6cycloalkyl; each of which is optionally substituted by 1 to 3 halogen atoms; R3 is isoxazolidin-2-ylcarbonyl or tetrahydroisoxazin-2-ylcarbonyl wherein each ring is optionally substituted by one hydroxy group; Q is -CO- or -C(R4)(R5)- in which R4 is a hydrogen atom or C1-4alkyl and R5 is a hydrogen atom or hydroxy group; and Ar is a 5- to 10-membered aromatic ring system in which up to 4 ring atoms may be heteroatoms independently selected from the group consisting of nitrogen, oxygen and sulphur, the ring system being optionally substituted by one or more substituents as defined in the specification. It also relates to methods of preparing, pharmaceutical compositions containing and methods of using the compound of the formula (1), particularly in the modulation of autoimmune disease.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjTEKwkAQRdNYiHoFmQPEQkTUctlMzIA7s-yshVUIslaigXgDL24iKeysPu_zPn-avWNFyOIvgRwVxFiQMGoOPohFVSglQKyQQt-gN8HEXsjBivOiNIB-IZASHwfVgeFi3JwVgXiA3zlICa5_ssYhR51nk1tz79JizFm2LDHaapXaZ526trmmR3rVdFpvD7v91mz-Ch8lnTxc</recordid><startdate>20091118</startdate><enddate>20091118</enddate><creator>RUKHSANA TASNEEM RASUL</creator><creator>MARTIN EDWARD COOPER</creator><creator>RACHEL HEULWEN REYNOLDS</creator><creator>ANTHONY HOWARD INGALL</creator><creator>SIMON DAVID GUILE</creator><scope>EVB</scope></search><sort><creationdate>20091118</creationdate><title>THIENOPYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION, COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE PREPARATION OF MEDICAMENTS</title><author>RUKHSANA TASNEEM RASUL ; MARTIN EDWARD COOPER ; RACHEL HEULWEN REYNOLDS ; ANTHONY HOWARD INGALL ; SIMON DAVID GUILE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IL159785A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RUKHSANA TASNEEM RASUL</creatorcontrib><creatorcontrib>MARTIN EDWARD COOPER</creatorcontrib><creatorcontrib>RACHEL HEULWEN REYNOLDS</creatorcontrib><creatorcontrib>ANTHONY HOWARD INGALL</creatorcontrib><creatorcontrib>SIMON DAVID GUILE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RUKHSANA TASNEEM RASUL</au><au>MARTIN EDWARD COOPER</au><au>RACHEL HEULWEN REYNOLDS</au><au>ANTHONY HOWARD INGALL</au><au>SIMON DAVID GUILE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THIENOPYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION, COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE PREPARATION OF MEDICAMENTS</title><date>2009-11-18</date><risdate>2009</risdate><abstract>The invention relates to a compound of formula (1): in which R1 and R2 each independently represent a C1-6alkyl, C3-6alkenyl, C3-6cycloalkylC1-3alkyl or C3-6cycloalkyl; each of which is optionally substituted by 1 to 3 halogen atoms; R3 is isoxazolidin-2-ylcarbonyl or tetrahydroisoxazin-2-ylcarbonyl wherein each ring is optionally substituted by one hydroxy group; Q is -CO- or -C(R4)(R5)- in which R4 is a hydrogen atom or C1-4alkyl and R5 is a hydrogen atom or hydroxy group; and Ar is a 5- to 10-membered aromatic ring system in which up to 4 ring atoms may be heteroatoms independently selected from the group consisting of nitrogen, oxygen and sulphur, the ring system being optionally substituted by one or more substituents as defined in the specification. It also relates to methods of preparing, pharmaceutical compositions containing and methods of using the compound of the formula (1), particularly in the modulation of autoimmune disease.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_IL159785A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title THIENOPYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION, COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE PREPARATION OF MEDICAMENTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T00%3A07%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RUKHSANA%20TASNEEM%20RASUL&rft.date=2009-11-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIL159785A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true